News Archives - Migraine Australia

Stigma survey: Migraine stigma affects 94% of people living with migraine

Results of our recent survey on the stigma of migraine have found that only 6% of people living with migraine…

Today in the House of Representatives, Health Minister Greg Hunt accused Eli Lilly of running an ‘AstroTurf’ campaign because they…

The TGA has recently announced that they will allow two types of triptans to be available from pharmacies from February…

June is Migraine Awareness Month and we are just so excited! There’s a lot going on. Most of the activity…

Australia is joining the world migraine community for the first time in celebrating Migraine Awareness Month throughout June. Patient advocacy…

Tell your story and become a face of migraine.

PBAC has decided to defer their decision on Ajovy, but it’s not a ‘no’.

All three CGRP antagonist monoclonal antibodies, Aimovig, Emgality and Ajovy, are all now available with a private prescription.

Let’s start getting heard.

Migraine Australia responds to Novartis’ decision to walk away from the PBS process.